Table 1

Patient characteristics, mean standardized uptake value (SUV), tumor:nontumor ratio (TNT), mitotic score, MIB-1 score, and grading

PatientSexAgeDiagnosisMaxa diameter (cm)LocationSUV tumorSUV nontumorTNTMitotic scorebFrench tumor gradebMIB-1 scorecJapanese tumor gradec
1M55Well-differentiated liposarcoma17Leg0.20.12.41111
2M55Myxoid liposarcoma10Leg1.10.52.11111
3M62Myxoid liposarcoma11Leg1.50.62.41111
4M71Recurrent MFH2Leg1.00.61.71111
5F61Well-differentiated liposarcoma30Leg0.40.70.61111
6F73Well-differentiated liposarcoma22Leg0.90.61.51111
7M27Epitheloid sarcoma7Leg1.40.62.31222
8M28Synoviasarcoma12Leg0.80.42.11222
9M33Myxofibrosarcoma17Leg3.40.65.42222
10M70Pleiomorphic MFH10Leg3.70.65.92222
11F71Leiomyosarcoma (recurrence)7Arm2.10.63.42222
12F75Myxofibrosarcoma14Leg3.50.66.41211
13M52Pleiomorphic MFH20Leg2.80.47.02323
Pleiomorphic MFH (recurrence in opposite leg)2Leg2.30.37.12323
14M53Pleiomorphic liposarcoma28Leg2.20.63.43333
15M70Myxofibrosarcoma10Leg2.30.54.72333
16M71Pleiomorphic leiomyosarcoma20Leg4.90.76.62333
17F47Pleiomorphic leiomyosarcoma11Arm4.80.95.33333
18F56Extraskeletal osteosarcoma6Leg2.80.39.33333
19F58Pleiomorphic sarcoma NOS5Leg3.71.52.53333
  • a Max, maximum; NOS, not otherwise specified; MFH, malignant fibrous histocytoma.

  • b Ref. 5 .

  • c Refs. 6 and 7 .